{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:51:40Z","timestamp":1769719900814,"version":"3.49.0"},"reference-count":58,"publisher":"Baishideng Publishing Group Inc.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4254\/wjh.v4.i12.335","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T08:37:56Z","timestamp":1509611876000},"page":"335","source":"Crossref","is-referenced-by-count":10,"title":["Management of alcoholic hepatitis: Current concepts"],"prefix":"10.4254","volume":"4","author":[{"given":"Hetal A","family":"Karsan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology 2010;51:307-328.","DOI":"10.1002\/hep.23258"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-199.","DOI":"10.1016\/0016-5085(78)90401-8"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Mathurin P, Duchatelle V, Ramond MJ, Degott C, Bedossa P, Erlinger S, Benhamou JP, Chaput JC, Rueff B, Poynard T. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847-1853.","DOI":"10.1053\/gast.1996.v110.pm8964410"},{"key":"ref4","unstructured":"Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http: \/\/www.ahrq.gov\/clinic\/epcsums\/alcosumm.htm\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http: \/\/www.ahrq.gov\/clinic\/epcsums\/alcosumm.htm<\/ext-link>."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Srisurapanont M, Jarusuraisin N. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2005;CD001867.","DOI":"10.1002\/14651858.CD001867.pub2"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Mason BJ. Acamprosate in the treatment of alcohol dependence. Expert Opin Pharmacother 2005;6:2103-2115.","DOI":"10.1517\/14656566.6.12.2103"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mendenhall CL, Tosch T, Weesner RE, Garcia-Pont P, Goldberg SJ, Kiernan T, Seeff LB, Sorell M, Tamburro C, Zetterman R. VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 1986;43:213-218.","DOI":"10.1093\/ajcn\/43.2.213"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Mendenhall C, Bongiovanni G, Goldberg S, Miller B, Moore J, Rouster S, Schneider D, Tamburro C, Tosch T, Weesner R. VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. JPEN J Parenter Enteral Nutr 1985;9:590-596.","DOI":"10.1177\/0148607185009005590"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Calvey H, Davis M, Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. J Hepatol 1985;1:141-151.","DOI":"10.1016\/S0168-8278(85)80762-5"},{"key":"ref10","unstructured":"Achord JL. Malnutrition and the role of nutritional support in alcoholic liver disease. Am J Gastroenterol 1987;82:1-7."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Soberon S, Pauley MP, Duplantier R, Fan A, Halsted CH. Metabolic effects of enteral formula feeding in alcoholic hepatitis. Hepatology 1987;7:1204-1209.","DOI":"10.1002\/hep.1840070606"},{"key":"ref12","unstructured":"Nasrallah SM, Galambos JT. Aminoacid therapy of alcoholic hepatitis. Lancet 1980;2:1276-1277."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Porter HP, Simon FR, Pope CE, Volwiler W, Fenster LF. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. N Engl J Med 1971;284:1350-1355.","DOI":"10.1056\/NEJM197106172842404"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Helman RA, Temko MH, Nye SW, Fallon HJ. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med 1971;74:311-321.","DOI":"10.7326\/0003-4819-74-3-311"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Campra JL, Hamlin EM, Kirshbaum RJ, Olivier M, Redeker AG, Reynolds TB. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. Ann Intern Med 1973;79:625-631.","DOI":"10.7326\/0003-4819-79-5-625"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Blitzer BL, Mutchnick MG, Joshi PH, Phillips MM, Fessel JM, Conn HO. Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study. Am J Dig Dis 1977;22:477-484.","DOI":"10.1007\/BF01072499"},{"key":"ref17","unstructured":"Shumaker JB, Resnick RH, Galambos JT, Makopour H, Iber FL. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients. Am J Gastroenterol 1978;69:443-449."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Lesesne HR, Bozymski EM, Fallon HJ. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Gastroenterology 1978;74:169-173.","DOI":"10.1016\/0016-5085(78)90790-4"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Depew W, Boyer T, Omata M, Redeker A, Reynolds T. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 1980;78:524-529.","DOI":"10.1016\/0016-5085(80)90867-7"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Theodossi A, Eddleston AL, Williams R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 1982;23:75-79.","DOI":"10.1136\/gut.23.1.75"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Mendenhall CL, Anderson S, Garcia-Pont P, Goldberg S, Kiernan T, Seeff LB, Sorrell M, Tamburro C, Weesner R, Zetterman R. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984;311:1464-1470.","DOI":"10.1056\/NEJM198412063112302"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Carithers RL, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989;110:685-690.","DOI":"10.7326\/0003-4819-110-9-685"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Ramond MJ, Poynard T, Rueff B, Mathurin P, Th&eacute;odore C, Chaput JC, Benhamou JP. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-512.","DOI":"10.1056\/NEJM199202203260802"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Imperiale TF, McCullough AJ. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med 1990;113:299-307.","DOI":"10.7326\/0003-4819-113-4-299"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995;37:113-118.","DOI":"10.1136\/gut.37.1.113"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Systematic review: glucocorticosteroids for alcoholic hepatitis--a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 2008;27:1167-1178.","DOI":"10.1111\/j.1365-2036.2008.03685.x"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Mathurin P, Mendenhall CL, Carithers RL, Ramond MJ, Maddrey WC, Garstide P, Rueff B, Naveau S, Chaput JC, Poynard T. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002;36:480-487.","DOI":"10.1016\/S0168-8278(01)00289-6"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007;45:1348-1354.","DOI":"10.1002\/hep.21607"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-2036.","DOI":"10.1111\/j.1572-0241.1998.00587.x"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Cabr&eacute; E, Rodr&iacute;guez-Iglesias P, Caballer&iacute;a J, Quer JC, S&aacute;nchez-Lombra\u00f1a JL, Par&eacute;s A, Papo M, Planas R, Gassull MA. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000;32:36-42.","DOI":"10.1053\/jhep.2000.8627"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:1637-1648.","DOI":"10.1053\/gast.2000.20189"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Naveau S, Chollet-Martin S, Dharancy S, Mathurin P, Jouet P, Piquet MA, Davion T, Oberti F, Bro&euml;t P, Emilie D. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004;39:1390-1397.","DOI":"10.1002\/hep.20206"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B, Boardman L, Gores GJ, Harmsen WS, McClain CJ. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 2008;135:1953-1960.","DOI":"10.1053\/j.gastro.2008.08.057"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Lieber CS, DeCarli LM, Mak KM, Kim CI, Leo MA. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 1990;12:1390-1398.","DOI":"10.1002\/hep.1840120621"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Mato JM, C&aacute;mara J, Fern&aacute;ndez de Paz J, Caballer&iacute;a L, Coll S, Caballero A, Garc&iacute;a-Buey L, Beltr&aacute;n J, Benita V, Caballer&iacute;a J. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999;30:1081-1089.","DOI":"10.1016\/S0168-8278(99)80263-3"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Butcher GP, Rhodes JM, Walker R, Krasner N, Jackson MJ. The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification. J Hepatol 1993;19:105-109.","DOI":"10.1016\/S0168-8278(05)80183-7"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Sadrzadeh SM, Meydani M, Khettry U, Nanji AA. High-dose vitamin E supplementation has no effect on ethanol-induced pathological liver injury. J Pharmacol Exp Ther 1995;273:455-460.","DOI":"10.1016\/S0022-3565(25)09604-1"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105-113.","DOI":"10.1016\/0168-8278(89)90083-4"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Nguyen-Khac E, Thevenot T, Piquet MA, Benferhat S, Goria O, Chatelain D, Tramier B, Dewaele F, Ghrib S, Rudler M. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med 2011;365:1781-1789.","DOI":"10.1056\/NEJMoa1101214"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Hall&eacute; P, Par&eacute; P, Kaptein E, Kanel G, Redeker AG, Reynolds TB. Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology 1982;82:925-931.","DOI":"10.1016\/S0016-5085(82)80257-6"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Orrego H, Blake JE, Blendis LM, Compton KV, Israel Y. Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 1987;317:1421-1427.","DOI":"10.1056\/NEJM198712033172301"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Akriviadis EA, Steindel H, Pinto PC, Fong TL, Kanel G, Reynolds TB, Gupta S. Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis. Gastroenterology 1990;99:811-818.","DOI":"10.1016\/0016-5085(90)90973-5"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Bird GL, Prach AT, McMahon AD, Forrest JA, Mills PR, Danesh BJ. Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis. J Hepatol 1998;28:194-198.","DOI":"10.1016\/0168-8278(88)80005-9"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Baker AL, Jaspan JB, Haines NW, Hatfield GE, Krager PS, Schneider JF. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients. Gastroenterology 1981;80:1410-1414.","DOI":"10.1016\/0016-5085(81)90250-X"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Bird G, Lau JY, Koskinas J, Wicks C, Williams R. Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial. Hepatology 1991;14:1097-1101.","DOI":"10.1002\/hep.1840140625"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Trinchet JC, Balkau B, Poupon RE, Heintzmann F, Callard P, Gotheil C, Grange JD, Vetter D, Pauwels A, Labadie H. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial. Hepatology 1992;15:76-81.","DOI":"10.1002\/hep.1840150115"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Bonet H, Manez R, Kramer D, Wright HI, Gavaler JS, Baddour N, Van Thiel DH. Liver transplantation for alcoholic liver disease: survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. Alcohol Clin Exp Res 1993;17:1102-1106.","DOI":"10.1111\/j.1530-0277.1993.tb05671.x"},{"key":"ref48","unstructured":"Shakil AO, Pinna A, Demetris J, Lee RG, Fung JJ, Rakela J. Survival and quality of life after liver transplantation for acute alcoholic hepatitis. Liver Transpl Surg 1997;3:240-244."},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, Castel H, Duhamel A, Pageaux GP, Leroy V. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011;365:1790-1800.","DOI":"10.1056\/NEJMoa1105703"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Conjeevaram HS, Hart J, Lissoos TW, Schiano TD, Dasgupta K, Befeler AS, Millis JM, Baker AL. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation 1999;67:1562-1568.","DOI":"10.1097\/00007890-199906270-00010"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Moss AH, Siegler M. Should alcoholics compete equally for liver transplantation? JAMA 1991;265:1295-1298.","DOI":"10.1001\/jama.265.10.1295"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Gerhardt TC, Goldstein RM, Urschel HC, Tripp LE, Levy MF, Husberg BS, Jennings LW, Gonwa TA, Klintmalm GB. Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation 1996;62:1060-1063.","DOI":"10.1097\/00007890-199610270-00005"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"F&aacute;brega E, Crespo J, Casafont F, De las Heras G, de la Pe\u00f1a J, Pons-Romero F. Alcoholic recidivism after liver transplantation for alcoholic cirrhosis. J Clin Gastroenterol 1998;26:204-206.","DOI":"10.1097\/00004836-199804000-00011"},{"key":"ref54","unstructured":"Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994;20:105-110."},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keefe EB, Kneteman NM, Lake JR, Martin P, Rakela J. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation 1998;66:956-962.","DOI":"10.1097\/00007890-199810150-00034"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"O'Grady JG. Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet's nest! Gut 2006;55:1529-1531.","DOI":"10.1136\/gut.2005.090506"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-330.","DOI":"10.1046\/j.1525-1594.1999.06122.x"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003;38:24-31.","DOI":"10.1016\/S0168-8278(02)00334-3"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v4\/i12\/335.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T20:51:41Z","timestamp":1750971101000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v4\/i12\/335.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v4.i12.335","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}